UIG News
About UIG
References
UIG Services
Contact Us
Tax inversion deal collapses: Will others follow suit?
A planned $2.7 billion deal between pharma companies Salix and Cosmo, motivated in part by the opportunity to do a tax inversion, has fallen through.
«
Euro zone retail sales much st...
Bernanke mortgage bid ‘u...
»